|
Q4 2018
Filed on Feb 08, 2019
|
10,857
|
$18.59 - $21.69
$202K - $235K
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
11,800
|
$3.86 - $4.19
$45.5K - $49.4K
|
|
Asterias Biotherapeutics Inc
|
Q4 2018
Filed on Feb 08, 2019
|
16,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
9,239
|
$31.92 - $39.99
$295K - $369K
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
16,065
|
N/A
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
9,275
|
$27.93 - $35.83
$259K - $332K
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
4,000
|
$36.5 - $75.14
$146K - $301K
|
|
|
Q4 2018
Filed on Feb 08, 2019
|
3,101
|
$48.79 - $70.58
$151K - $219K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
11,563
|
$11.8 - $12.29
$136K - $142K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
4,875
|
$31.17 - $42.7
$152K - $208K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,036
|
$6.01 - $7.47
$60.3K - $75K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
4,828
|
$34.05 - $55.9
$164K - $270K
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
12,463
|
N/A
|
|
|
Q3 2018
Filed on Nov 09, 2018
|
10,000
|
$41.17 - $58.72
$412K - $587K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
45,181
|
N/A
|
|
Powershares Act Mang Comm Fd
|
Q2 2018
Filed on Aug 09, 2018
|
150,678
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
3,993
|
$48.34 - $60.3
$193K - $241K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
15,980
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
2,607
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
4,448
|
$47.52 - $55.88
$211K - $249K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
8,245
|
$113.81 - $117.24
$938K - $967K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
8,885
|
$22.5 - $29.6
$200K - $263K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
2,374,625
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
12,678
|
$21.94 - $24.82
$278K - $315K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
8,353
|
$36.64 - $48.92
$306K - $409K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
5,622
|
$44.49 - $61.48
$250K - $346K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
3,804
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
3,779
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
2,400
|
N/A
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
6,600
|
$44.26 - $60.23
$292K - $398K
|
|
|
Q2 2018
Filed on Aug 09, 2018
|
13,841
|
$10.82 - $12.11
$150K - $168K
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
7,800
|
N/A
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
3,277
|
$79.82 - $88.61
$262K - $290K
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
126,333
|
N/A
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
9,980
|
$24.06 - $29.4
$240K - $293K
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
7,850
|
$24.85 - $29.83
$195K - $234K
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
126,884
|
N/A
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
13,551
|
$13.02 - $14.42
$176K - $195K
|
|
|
Q1 2018
Filed on Apr 26, 2018
|
10,000
|
$7.9 - $10.16
$79K - $102K
|
|
Flaherty & Crumrine Dyn Pfd
|
Q4 2017
Filed on Feb 02, 2018
|
8,713
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
12,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
12,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
129
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
35,126
|
$73.23 - $93.79
$2.57M - $3.29M
|
|
Alexion Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 02, 2018
|
1,436
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
13,584
|
$11.62 - $14.96
$158K - $203K
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
789
|
$237.57 - $262.53
$187K - $207K
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
8,600
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
7,334
|
N/A
|
|
|
Q4 2017
Filed on Feb 02, 2018
|
5,734
|
$50.5 - $53.37
$290K - $306K
|
|